Appeals Court Overturns FTC Order On Settlements Of Drug Patent Disputes

Law360, New York (March 9, 2005, 12:00 AM EST) -- A federal appeals court has cleared Schering-Plough of violating antitrust laws in a patent litigation settlement with generic competitors, overturning an order by the U.S. Federal Trade Commission that would have had far-reaching implications for patent disputes in the drug industry.

The U.S. Court of Appeals for the 11th Circuit, based in Atlanta, ruled that Schering did not violate antitrust laws in patent litigation settlements involving its controlled-release potassium chloride supplement K-Dur 20.

The court reversed a 2003 finding by the FTC that drug makers Schering,...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.